Efficacy and Safety of Nasal Glucagon for Treatment of Insulin Induced Hypoglycemia in Adults With Diabetes
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Glucagon (Primary) ; Glucagon
- Indications Hypoglycaemia
- Focus Registrational; Therapeutic Use
- Sponsors AMG Medical; Eli Lilly and Company
- 25 Sep 2020 Results (n=214) of pooled post hoc analyses of 3 randomised, cross-over studies (NCT03421379, NCT03339453, NCT01994746) assessing efficacy and safety of nasal glucagon compared to 1 mg intramuscular injectable glucagon in reversing insulin-induced hypoglycaemia in adults with type 1 diabetes or type 2 diabetes, presented at the 56th Annual Meeting of the European Association for the Study of Diabetes.
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 17 Dec 2015 Results published in the Diabetes Care